BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liewen H, Markuly N, Läubli H, Liu Y, Matter MS, Liewen N, Renner C, Zippelius A, Stenner F. Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX). Target Oncol 2019;14:577-90. [PMID: 31541350 DOI: 10.1007/s11523-019-00667-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding D, Zhang Y, Zhang X, Shi K, Shang W, Ying J, Wang L, Chen Z, Hong H. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling. Mol Biotechnol 2022. [PMID: 35438415 DOI: 10.1007/s12033-022-00497-x] [Reference Citation Analysis]
2 Martins M, Fernandes AS, Saraiva N. GOLGI: cancer cell fate control. Int J Biochem Cell Biol 2022;:106174. [PMID: 35182766 DOI: 10.1016/j.biocel.2022.106174] [Reference Citation Analysis]
3 Xie L, Yi J, Song Y, Zhao M, Fan L, Zhao L. Suppression of GOLM1 by EGCG through HGF/HGFR/AKT/GSK-3β/β-catenin/c-Myc signaling pathway inhibits cell migration of MDA-MB-231. Food Chem Toxicol 2021;157:112574. [PMID: 34536514 DOI: 10.1016/j.fct.2021.112574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang Y, Qiu N, Zhang Y, Yan H, Ji J, Xi Y, Yang X, Zhao X, Zhai G. Oxygen-carrying nanoparticle-based chemo-sonodynamic therapy for tumor suppression and autoimmunity activation. Biomater Sci 2021;9:3989-4004. [PMID: 33908449 DOI: 10.1039/d1bm00198a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]